(Q43787220)

26 November 2017

title

Lack of evidence for peripheral alpha(1)- adrenoceptor blockade during long-term treatment of heart failure with carvedilol (English)

1 reference

26 November 2017

4

1 reference

26 November 2017

T Kubo

1

1 reference

26 November 2017

E R Azevedo

series ordinal

2

1 reference

26 November 2017

G E Newton

series ordinal

3

1 reference

26 November 2017

J S Floras

series ordinal

5

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Journal of the American College of Cardiology

26 November 2017

published in

1 reference

26 November 2017

volume

38

1 reference

26 November 2017

issue

5

1 reference

26 November 2017

page(s)

1463-1469

1 reference

Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

Adverse consequences of high sympathetic nervous activity in the failing human heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

After-effects of exercise on haemodynamics and muscle sympathetic nerve activity in young patients with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

Reductions in muscle sympathetic nerve activity after long-term metoprolol for dilated cardiomyopathy: preliminary observations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

Sympathetic alternans. Evidence for arterial baroreflex control of muscle sympathetic nerve activity in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

Haemodynamic effects of metoprolol and pindolol: a comparison in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

Sympathetic outflow to muscles during treatment of hypertension with metoprolol

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

Resting muscle sympathetic nerve activity and peak oxygen uptake in heart failure and normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

Impact of heart failure and exercise capacity on sympathetic response to handgrip exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

Sympathetic neural discharge and vascular resistance during exercise in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

Limb vasoconstriction after successful angioplasty of the left anterior descending coronary artery.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

Sympathetic vasoconstriction in active skeletal muscles during dynamic exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

Development of pharmacodynamic tolerance to prazosin in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

Combined alpha-beta blockade (doxazosin plus metoprolol) compared with beta blockade alone in chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

Frequency-response characteristics of vascular resistance vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901577-7

7 January 2021

10.1016/S0735-1097(01)01577-7

Identifiers

DOI

1 reference

26 November 2017

1 reference